AsiaIPEX is a one-stop-shop for players in the IP industry, facilitating IP trade and connection to the IP world. Whether you are a patent owner interested in selling your IP, or a manufacturer looking to buy technologies to upgrade your operation, you will find the portal a useful resource.
Antibody for targeting cancers characterized by increased iron uptake
Summary
Nicole Suciu-Foca, Ph.D.
Technology Benefits
Relevant to orphan diseases like Adult T Cell Leukemia and Mantle Cell LymphomaSpecifically targets cancer cells over healthy cellsTech Ventures Reference: IR CU14351Patent Information:Patent Pending
Technology Application
Cancer immunophenotyping In vitro sorting (e.g. using flow cytometry) of cells with TfR1 overexpression from healthy cellsTreatment of cancers characterized by TfR1 overexpressionIron replacement in pregnant womenTreatment for neurodegenerative diseases like Alzheimer's and Parkinson's
Detailed Technology Description
Nicole Suciu-Foca, Ph.D.
Country/Region
USA
For more information, please click Here
